Neuroprotective effect of ranolazine improves behavioral discrepancies in a rat model of scopolamine-induced dementia

Neuroprotective effect of ranolazine improves behavioral discrepancies in a rat model of scopolamine-induced dementia

BackgroundRanolazine (Rn), an antianginal agent, acts in the central nervous system and has been used as a potential treatment agent for pain and epileptic disorders. Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative diseases and the leading factor in dementia in the elderly.Ai...

Full description

Bibliographic Details
Main Authors: Shereen M. Samir, Hend M. Hassan, Rasha Elmowafy, Eman Mohamed ElNashar, Mansour Abdullah Alghamdi, Mona Hmoud AlSheikh, Norah Saeed Al-Zahrani, Faten Mohammed Alasiri, Mona G. Elhadidy
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Neuroscience
Subjects:
ranolazine
scopolamine
dementia
apoptosis
GFAP
tau
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2023.1267675/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2023.1267675/full

Similar Items